Australia's Strict E-cigarette Regulation: Impact and Concerns

Regulations by 2FIRSTS.ai
Jan.17.2024
Australia's Strict E-cigarette Regulation: Impact and Concerns
Australia is set to implement strict regulations on e-cigarette use, potentially causing an increase in doctor visits and prescriptions.

According to a recent report in Lung Health Magazine, the use of e-cigarettes in Australia is limited to those who have obtained a prescription from a doctor for quitting smoking, and the cost of obtaining a rechargeable e-cigarette from a doctor is estimated to be as high as $150.

 

New government data suggests that Australia is set to implement strict regulations on e-cigarettes, which is expected to result in approximately one million additional doctor visits and half of the Australian population seeking prescriptions for nicotine e-cigarettes each year. This situation arises at a time when factors such as low insurance coverage, exorbitant healthcare costs, and a nationwide shortage of doctors have made accessing medical care increasingly challenging.

 

Analysis suggests that if the new management system becomes overly complicated, young adults may turn to traditional tobacco use. Currently, there are approximately 1.3 million adult e-cigarette users in Australia, but only 8% of them have prescriptions.

 

The government report also warns that the high prices of prescription e-cigarettes could exacerbate the risk of black market sales. However, this analysis report supports the government's reform measures - strict regulation is considered the best approach to lower the rate of young Australians using e-cigarettes.

 

Ms. Danielle McMullen, Deputy Chair of the Australian Medical Association, affirmed in an interview with "The Project" that the medical industry is "ready to assist" those with nicotine addiction. She noted that although there may be challenges dealing with individuals addicted to and regularly using e-cigarettes in the short term, the healthcare sector is prepared to help these individuals address their nicotine dependence and discuss options for reducing smoking or using e-cigarettes.

 

Despite concerns that the new regulations would further burden an already strained healthcare system, Macmillan added, "Dealing with substance abuse issues is part of the fundamental work of general practitioners." She stated, "By restricting the import of disposable e-cigarettes, this is our best way to reduce the harm they pose to young people and ensure they are unable to access these harmful products.

 

McMallen further stated, "We strongly hope that this will alter the lifelong habit of nicotine addiction in the next generation of individuals." Please note that "McMallen" is not a recognized name, so I assumed it is a misspelling of a name or a fictional character. Please replace it with the correct name if applicable.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Australia’s TGA Places Nicotine Pouches Under Therapeutic Goods Rules From July 24, Blocking Imports of Unapproved Products
Australia’s TGA Places Nicotine Pouches Under Therapeutic Goods Rules From July 24, Blocking Imports of Unapproved Products
Australia is strengthening controls on nicotine pouches under its existing therapeutic goods regulatory framework. According to the Therapeutic Goods Administration (TGA), nicotine pouch products must meet regulatory requirements, and unapproved products cannot be legally imported. The move follows Australia’s broader approach of maintaining strict oversight of nicotine products, including nicotine-containing vapes. As nicotine pouches expand globally, Australia’s regulatory approach highlights growing differences in how countries manage emerging smoke-free nicotine products.
Regulations
Jul.27
Canada Recalls Siberia and ZYN Nicotine Pouches Over Unauthorized Sales
Canada Recalls Siberia and ZYN Nicotine Pouches Over Unauthorized Sales
Health Canada has issued a nationwide recall for nicotine pouch products sold under the Siberia and ZYN brands, citing a lack of market authorization. All affected lots are subject to the recall.
Jun.15
China Tobacco International HK Warns First-Half Revenue May Fall 25%-30%, Tobacco Leaf and Duty-Free Exposure Highlight Reliance on Traditional Tobacco
China Tobacco International HK Warns First-Half Revenue May Fall 25%-30%, Tobacco Leaf and Duty-Free Exposure Highlight Reliance on Traditional Tobacco
CTIHK expects first-half 2026 revenue to fall 25%-30%, mainly due to lower tobacco leaf imports and delayed cigarette shipments to China’s domestic duty-free market. Its 2025 revenue mix—nearly 90% from tobacco leaf-related businesses and less than 1% from new tobacco products—shows continued exposure to traditional supply chains and trade variables.
Jun.18
U.S. Military Nicotine Policy Sparks Debate as Nicotine Pouches Enter Discussion
U.S. Military Nicotine Policy Sparks Debate as Nicotine Pouches Enter Discussion
An opinion article published by Stars and Stripes argued that the Pentagon’s January nicotine clinical guidelines overemphasize abstinence, fail to reflect the reality that about 30% of active-duty personnel use nicotine, and do not address nicotine pouches as potential harm-reduction products.
Industry Insight
Jun.08
BAT UK Director Tolga Kilic Says Illicit Nicotine Market Squeezes Legal Retailers Amid Rising Compliance Costs
BAT UK Director Tolga Kilic Says Illicit Nicotine Market Squeezes Legal Retailers Amid Rising Compliance Costs
UK retail publication Grocery Trader has published a viewpoint article from Tolga Kilic, Commercial Director for BAT UK & Ireland, discussing the impact of illicit nicotine products on legitimate retail channels. Kilic said illegal vapes and other illicit nicotine products create competitive pressure for compliant retailers and called for stronger market controls and supply-chain oversight. The comments come as the UK advances policies including the disposable vape ban and Vaping Products Duty, creating a more complex operating environment for legal vape retailers.
Jul.28
FDA Grants MRTP Orders for 20 ZYN Nicotine Pouches
FDA Grants MRTP Orders for 20 ZYN Nicotine Pouches
The U.S. Food and Drug Administration (FDA) has issued modified risk granted orders to Swedish Match USA for 20 ZYN nicotine pouch products, allowing the already-authorized products to be marketed with a specific claim that using ZYN instead of cigarettes lowers the risk of mouth cancer, heart disease, lung cancer, stroke, emphysema and chronic bronchitis.
Jul.01